| 1 | 270706 | On the enzymic defects in hereditary tyrosinemia. | Proc Natl Acad Sci U S A | 1977 Oct |
3 |
| 2 | 1749221 | Tyrosinaemia type I--an update. | J Inherit Metab Dis | 1991 |
2 |
| 3 | 1998338 | Cloning and expression of the cDNA encoding human fumarylacetoacetate hydrolase, the enzyme deficient in hereditary tyrosinemia: assignment of the gene to chromosome 15. | Am J Hum Genet | 1991 Mar |
2 |
| 4 | 2195095 | Purification of human liver fumarylacetoacetase using immunoaffinity chromatography. | J Biochem Biophys Methods | 1990 Apr-May |
1 |
| 5 | 2378356 | Different molecular basis for fumarylacetoacetate hydrolase deficiency in the two clinical forms of hereditary tyrosinemia (type I). | Am J Hum Genet | 1990 Aug |
2 |
| 6 | 2378358 | Fumarylacetoacetase measurement as a mass-screening procedure for hereditary tyrosinemia type I. | Am J Hum Genet | 1990 Aug |
1 |
| 7 | 3296130 | Hereditary tyrosinemia type I--an overview. | Scand J Clin Lab Invest Suppl | 1986 |
2 |
| 8 | 3473612 | The pre- and post-natal diagnosis of tyrosinemia type I and the detection of the carrier state by assay of fumarylacetoacetase. | Scand J Clin Lab Invest Suppl | 1986 |
1 |
| 9 | 4064334 | Concentrations of succinylacetone after homogentisate and tyrosine loading in healthy individuals with low fumarylacetoacetase activity. | Clin Chim Acta | 1985 Nov 15 |
1 |
| 10 | 6547574 | Optimal conditions for 4-hydroxybenzoyl- and 2-furoylhydrazine as reagents for the determination of carbohydrates, including ketosamines. | Anal Biochem | 1984 May 15 |
4 |
| 11 | 6652907 | Biochemical studies on the enzymatic deficiencies in hereditary tyrosinemia. | Clin Chim Acta | 1983 Oct 31 |
2 |
| 12 | 6826727 | Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone. | J Clin Invest | 1983 Mar |
2 |
| 13 | 6872257 | Urinary excretion of deuterated metabolites in patients with tyrosinemia type I after oral loading with deuterated L-tyrosine. | Clin Chim Acta | 1983 May 30 |
1 |
| 14 | 7182986 | Succinylacetone inhibits delta-aminolevulinate dehydratase and potentiates the drug and steroid induction of delta-aminolevulinate synthase in liver. | Trans Assoc Am Physicians | 1982 |
2 |
| 15 | 7568087 | Fungal metabolic model for human type I hereditary tyrosinaemia. | Proc Natl Acad Sci U S A | 1995 Sep 26 |
1 |
| 16 | 7623442 | Tyrosinaemia type 1 and glutathione synthetase deficiency: two disorders with reduced hepatic thiol group concentrations and a liver 4-fumarylacetoacetate hydrolase deficiency. | J Inherit Metab Dis | 1995 |
1 |
| 17 | 7702626 | Correction of fumarylacetoacetate hydrolase deficiency (type I tyrosinemia) in cultured human fibroblasts by retroviral-mediated gene transfer. | Biochem Biophys Res Commun | 1995 Mar 28 |
1 |
| 18 | 8162054 | Identification of a stop mutation in five Finnish patients suffering from hereditary tyrosinemia type I. | Hum Mol Genet | 1994 Jan |
3 |
| 19 | 8204664 | Structural organization and analysis of the human fumarylacetoacetate hydrolase gene in tyrosinemia type I. | Biochim Biophys Acta | 1994 May 25 |
2 |
| 20 | 8364576 | Characterization of the human fumarylacetoacetate hydrolase gene and identification of a missense mutation abolishing enzymatic activity. | Hum Mol Genet | 1993 Jul |
4 |
| 21 | 8790725 | Tyrosine and its catabolites: from disease to cancer. | Acta Biochim Pol | 1996 |
1 |
| 22 | 8889268 | Tyrosinemia: the Quebec experience. | Clin Invest Med | 1996 Oct |
2 |
| 23 | 9101289 | Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: overview. | Hum Mutat | 1997 |
2 |
| 24 | 9392420 | Diacylglycerol is the preferred substrate in high density lipoproteins for human hepatic lipase. | J Lipid Res | 1997 Nov |
7 |
| 25 | 9728331 | Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione). | J Inherit Metab Dis | 1998 Aug |
1 |
| 26 | 9770534 | Deficient DNA-ligase activity in the metabolic disease tyrosinemia type I. | Proc Natl Acad Sci U S A | 1998 Oct 13 |
1 |
| 27 | 10049978 | Tyrosinemia type 1 should be suspected in infants with severe coagulopathy even in the absence of other signs of liver failure. | Pediatrics | 1999 Mar |
1 |
| 28 | 10331655 | Mechanisms of cellular uptake of long chain free fatty acids. | Mol Cell Biochem | 1999 Feb |
1 |
| 29 | 10508789 | Crystal structure and mechanism of a carbon-carbon bond hydrolase. | Structure | 1999 Sep 15 |
15 |
| 30 | 10593876 | Cyclin B-dependent kinase and caspase-1 activation precedes mitochondrial dysfunction in fumarylacetoacetate-induced apoptosis. | FASEB J | 1999 Dec |
6 |
| 31 | 11154690 | Mechanistic inferences from the crystal structure of fumarylacetoacetate hydrolase with a bound phosphorus-based inhibitor. | J Biol Chem | 2001 May 4 |
17 |
| 32 | 11209059 | Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1. | Proc Natl Acad Sci U S A | 2001 Jan 16 |
7 |
| 33 | 11234769 | Fibrillar amyloid beta-protein forms a membrane-like hydrophobic domain. | Neuroreport | 2001 Mar 5 |
1 |
| 34 | 11278491 | Structural and functional analysis of missense mutations in fumarylacetoacetate hydrolase, the gene deficient in hereditary tyrosinemia type 1. | J Biol Chem | 2001 May 4 |
2 |
| 35 | 11476670 | A missense mutation (Q279R) in the fumarylacetoacetate hydrolase gene, responsible for hereditary tyrosinemia, acts as a splicing mutation. | BMC Genet | 2001 |
2 |
| 36 | 11532983 | Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability. | Hum Mol Genet | 2001 Aug 15 |
8 |
| 37 | 12052898 | Maleylacetoacetate isomerase (MAAI/GSTZ)-deficient mice reveal a glutathione-dependent nonenzymatic bypass in tyrosine catabolism. | Mol Cell Biol | 2002 Jul |
4 |
| 38 | 12899938 | Pharmacological rescue of the 14CoS/14CoS mouse: hepatocyte apoptosis is likely caused by endogenous oxidative stress. | Free Radic Biol Med | 2003 Aug 15 |
1 |
| 39 | 12944177 | A potential biomarker of kidney damage identified by proteomics: preliminary findings. | Biomarkers | 2003 May-Aug |
6 |
| 40 | 14613010 | [Hereditary tyrosinemia: an endoplasmic reticulum stress disorder?]. | Med Sci (Paris) | 2003 Oct |
1 |
| 41 | 15521007 | No evidence of maternal cell colonization in reverted liver nodules of tyrosinemia type I patients. | Gastroenterology | 2004 Nov |
2 |
| 42 | 15551868 | X-ray structure of fumarylacetoacetate hydrolase family member Homo sapiens FLJ36880. | Biol Chem | 2004 Oct |
2 |
| 43 | 16263080 | DNA damage and repair in mammalian cells exposed to p-hydroxyphenylpyruvic acid. | Biochem Biophys Res Commun | 2005 Dec 16 |
1 |
| 44 | 16414314 | A GC/MS validated method for the nanomolar range determination of succinylacetone in amniotic fluid and plasma: an analytical tool for tyrosinemia type I. | J Chromatogr B Analyt Technol Biomed Life Sci | 2006 Feb 17 |
2 |
| 45 | 16492973 | Kidneys of mice with hereditary tyrosinemia type I are extremely sensitive to cytotoxicity. | Pediatr Res | 2006 Mar |
4 |
| 46 | 17064256 | Slow-onset inhibition of fumarylacetoacetate hydrolase by phosphinate mimics of the tetrahedral intermediate: kinetics, crystal structure and pharmacokinetics. | Biochem J | 2007 Mar 1 |
10 |
| 47 | 17881244 | Charge-remote fragmentation of lithiated fatty acids on a TOF-TOF instrument using matrix-ionization. | J Am Soc Mass Spectrom | 2007 Nov |
2 |
| 48 | 19569981 | Clinical, biochemical, and genetic analysis of a Korean neonate with hereditary tyrosinemia type 1. | Clin Chem Lab Med | 2009 |
2 |
| 49 | 20003495 | A novel mutation causing mild, atypical fumarylacetoacetase deficiency (Tyrosinemia type I): a case report. | Orphanet J Rare Dis | 2009 Dec 15 |
4 |
| 50 | 21308989 | Hypermethioninemias of genetic and non-genetic origin: A review. | Am J Med Genet C Semin Med Genet | 2011 Feb 15 |
1 |